RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy (STREAM)

Trial Profile

RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy (STREAM)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 26 May 2017

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Myocardial infarction; Unstable angina pectoris
  • Focus Therapeutic Use
  • Acronyms STREAM
  • Sponsors AstraZeneca
  • Most Recent Events

    • 20 Feb 2017 Planned End Date changed from 1 Jun 2018 to 1 Jul 2018.
    • 20 Feb 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jul 2018.
    • 03 Aug 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top